tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CH:ROG Stock Latest News

Roche says 760 ambulatory DMD patients treated with Elevidys with no deaths
The FlyRoche says 760 ambulatory DMD patients treated with Elevidys with no deaths
12h ago
CHRO
SRPT
Roche says set to resume shipments of Sarepta’s Elevidys outside U.S.
PremiumThe Fly
Roche says set to resume shipments of Sarepta’s Elevidys outside U.S.
12h ago
CHRO
SRPT
Trump administration mulls charging patent holders 1%-5% fee, WSJ reports
PremiumThe Fly
Trump administration mulls charging patent holders 1%-5% fee, WSJ reports
1d ago
AZN
BMY
Roche price target raised to CHF 230 from CHF 220 at JPMorgan
PremiumThe Fly
Roche price target raised to CHF 230 from CHF 220 at JPMorgan
1d ago
CHRO
Genentech to present new data from Alzheimer’s development portfolio
PremiumThe Fly
Genentech to present new data from Alzheimer’s development portfolio
2d ago
CHRO
Roche plans to test if new medicine can prevent AD symptoms, Bloomberg says
PremiumThe FlyRoche plans to test if new medicine can prevent AD symptoms, Bloomberg says
2d ago
CHRO
Roche says will work with EMA on path forward for Elevidys
Premium
The Fly
Roche says will work with EMA on path forward for Elevidys
5d ago
CHRO
SRPT
European Union committee recommends against Sarepta’s Elevidys
Premium
The Fly
European Union committee recommends against Sarepta’s Elevidys
5d ago
CHRO
SRPT
Brazil suspends sales of Sarepta’s Elevidys after deaths
PremiumThe Fly
Brazil suspends sales of Sarepta’s Elevidys after deaths
5d ago
CHRO
SRPT
Roche Reports Strong Sales Growth in H1 2025
PremiumCompany Announcements
Roche Reports Strong Sales Growth in H1 2025
5d ago
Sarepta price target lowered to $35 from $40 at Jefferies
PremiumThe Fly
Sarepta price target lowered to $35 from $40 at Jefferies
6d ago
CHRO
SRPT
Roche says Brazilian death unrelated to Elevidys, Bloomberg reports
PremiumThe Fly
Roche says Brazilian death unrelated to Elevidys, Bloomberg reports
6d ago
CHRO
SRPT
Roche says Elevidys benefit-risk in ambulatory patients remains positive
PremiumThe FlyRoche says Elevidys benefit-risk in ambulatory patients remains positive
6d ago
CHRO
SRPT
H.C. Wainwright sees rejection for Sarepta in Europe tomorrow
Premium
The Fly
H.C. Wainwright sees rejection for Sarepta in Europe tomorrow
6d ago
CHRO
SRPT
Roche Holding AG: Hold Rating Amid Mixed Financial Signals and Strategic Challenges
Premium
Ratings
Roche Holding AG: Hold Rating Amid Mixed Financial Signals and Strategic Challenges
6d ago
CHRO
Roche reports 1H group sales CHF 30.9B vs. CHF 29.8B last year
PremiumThe Fly
Roche reports 1H group sales CHF 30.9B vs. CHF 29.8B last year
6d ago
CHRO
Roche sees FY25 core EPS growing in high single digit range
PremiumThe Fly
Roche sees FY25 core EPS growing in high single digit range
6d ago
CHRO
Roche receives CE Mark for Elecsys pTau181
PremiumThe Fly
Roche receives CE Mark for Elecsys pTau181
7d ago
LLY
CHRO
Roche pauses shipments of Elevidys outside the U.S., Bloomberg says
PremiumThe Fly
Roche pauses shipments of Elevidys outside the U.S., Bloomberg says
7d ago
CHRO
Roche announces European Commission approved Itovebi
PremiumThe FlyRoche announces European Commission approved Itovebi
7d ago
CHRO
Roche announces ALIENTO trial meets, ARNASA study misses primary endpoint
Premium
The Fly
Roche announces ALIENTO trial meets, ARNASA study misses primary endpoint
9d ago
CHRO
Genetech: STARGLO data does not provide sufficient evidence for DLBCL indication
Premium
The Fly
Genetech: STARGLO data does not provide sufficient evidence for DLBCL indication
11d ago
CHRO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >